Literature DB >> 17057096

Virulent Salmonella enterica serovar typhimurium evades adaptive immunity by preventing dendritic cells from activating T cells.

Jaime A Tobar1, Leandro J Carreño, Susan M Bueno, Pablo A González, Jorge E Mora, Sergio A Quezada, Alexis M Kalergis.   

Abstract

Dendritic cells (DCs) constitute the link between innate and adaptive immunity by directly recognizing pathogen-associated molecular patterns (PAMPs) in bacteria and by presenting bacterial antigens to T cells. Recognition of PAMPs renders DCs as professional antigen-presenting cells able to prime naïve T cells and initiate adaptive immunity against bacteria. Therefore, interfering with DC function would promote bacterial survival and dissemination. Understanding the molecular mechanisms that have evolved in virulent bacteria to evade activation of adaptive immunity requires the characterization of virulence factors that interfere with DC function. Salmonella enterica serovar Typhimurium, the causative agent of typhoid-like disease in the mouse, can prevent antigen presentation to T cells by avoiding lysosomal degradation in DCs. Here, we show that this feature of virulent Salmonella applies in vivo to prevent activation of adaptive immunity. In addition, this attribute of virulent Salmonella requires functional expression of a type three secretion system (TTSS) and effector proteins encoded within the Salmonella pathogenicity island 2 (SPI-2). In contrast to wild-type virulent Salmonella, mutant strains carrying specific deletions of SPI-2 genes encoding TTSS components or effectors proteins are targeted to lysosomes and are no longer able to prevent DCs from activating T cells in vitro or in vivo. SPI-2 mutant strains are attenuated in vivo, showing reduced tissue colonization and enhanced T-cell activation, which confers protection against a challenge with wild-type virulent Salmonella. Our data suggest that impairment of DC function by the activity of SPI-2 gene products is crucial for Salmonella pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17057096      PMCID: PMC1695529          DOI: 10.1128/IAI.00063-06

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  54 in total

Review 1.  The role of dendritic cells in the immune response to Salmonella.

Authors:  Mary Jo Wick
Journal:  Immunol Lett       Date:  2003-01-22       Impact factor: 3.685

Review 2.  Trafficking of the Salmonella vacuole in macrophages.

Authors:  David W Holden
Journal:  Traffic       Date:  2002-03       Impact factor: 6.215

3.  Complete genome sequence of Salmonella enterica serovar Typhimurium LT2.

Authors:  M McClelland; K E Sanderson; J Spieth; S W Clifton; P Latreille; L Courtney; S Porwollik; J Ali; M Dante; F Du; S Hou; D Layman; S Leonard; C Nguyen; K Scott; A Holmes; N Grewal; E Mulvaney; E Ryan; H Sun; L Florea; W Miller; T Stoneking; M Nhan; R Waterston; R K Wilson
Journal:  Nature       Date:  2001-10-25       Impact factor: 49.962

4.  Entry and survival of Salmonella typhimurium in dendritic cells and presentation of recombinant antigens do not require macrophage-specific virulence factors.

Authors:  F Niedergang; J C Sirard; C T Blanc; J P Kraehenbuhl
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

5.  SpiC is required for secretion of Salmonella Pathogenicity Island 2 type III secretion system proteins.

Authors:  Xiu-Jun Yu; Javier Ruiz-Albert; Kate E Unsworth; Steven Garvis; Mei Liu; David W Holden
Journal:  Cell Microbiol       Date:  2002-08       Impact factor: 3.715

Review 6.  Functions and effectors of the Salmonella pathogenicity island 2 type III secretion system.

Authors:  Scott R Waterman; David W Holden
Journal:  Cell Microbiol       Date:  2003-08       Impact factor: 3.715

7.  Mycobacterium tuberculosis inhibits maturation of human monocyte-derived dendritic cells in vitro.

Authors:  Willem A Hanekom; Megan Mendillo; Claudia Manca; Patrick A J Haslett; M Ruby Siddiqui; Clifton Barry; Gilla Kaplan
Journal:  J Infect Dis       Date:  2003-07-09       Impact factor: 5.226

8.  SpiC is required for translocation of Salmonella pathogenicity island 2 effectors and secretion of translocon proteins SseB and SseC.

Authors:  Jeremy A Freeman; Catherine Rappl; Volker Kuhle; Michael Hensel; Samuel I Miller
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

9.  Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance.

Authors:  Laura Bonifaz; David Bonnyay; Karsten Mahnke; Miguel Rivera; Michel C Nussenzweig; Ralph M Steinman
Journal:  J Exp Med       Date:  2002-12-16       Impact factor: 14.307

10.  Inducing tumor immunity through the selective engagement of activating Fcgamma receptors on dendritic cells.

Authors:  Alexis M Kalergis; Jeffrey V Ravetch
Journal:  J Exp Med       Date:  2002-06-17       Impact factor: 14.307

View more
  47 in total

1.  Selective culling of high avidity antigen-specific CD4+ T cells after virulent Salmonella infection.

Authors:  James M Ertelt; Tanner M Johanns; Margaret A Mysz; Minelva R Nanton; Jared H Rowe; Marijo N Aguilera; Sing Sing Way
Journal:  Immunology       Date:  2011-12       Impact factor: 7.397

2.  Vaccination with a single CD4 T cell peptide epitope from a Salmonella type III-secreted effector protein provides protection against lethal infection.

Authors:  Jonathan R Kurtz; Hailey E Petersen; Daniel R Frederick; Lisa A Morici; James B McLachlan
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

3.  Immune complex-induced enhancement of bacterial antigen presentation requires Fcgamma receptor III expression on dendritic cells.

Authors:  Andrés A Herrada; Francisco J Contreras; Jaime A Tobar; Rodrigo Pacheco; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-06       Impact factor: 11.205

4.  Guanylate Binding Proteins Regulate Inflammasome Activation in Response to Hyperinjected Yersinia Translocon Components.

Authors:  Erin E Zwack; Eric M Feeley; Amanda R Burton; Baofeng Hu; Masahiro Yamamoto; Thirumala-Devi Kanneganti; James B Bliska; Jörn Coers; Igor E Brodsky
Journal:  Infect Immun       Date:  2017-09-20       Impact factor: 3.441

5.  Direct visualization of endogenous Salmonella-specific B cells reveals a marked delay in clonal expansion and germinal center development.

Authors:  Minelva R Nanton; Seung-Joo Lee; Shaikh M Atif; Sean-Paul Nuccio; Justin J Taylor; Andreas J Bäumler; Sing Sing Way; Stephen J McSorley
Journal:  Eur J Immunol       Date:  2014-11-20       Impact factor: 5.532

6.  Respiratory syncytial virus impairs T cell activation by preventing synapse assembly with dendritic cells.

Authors:  Pablo A González; Carolina E Prado; Eduardo D Leiva; Leandro J Carreño; Susan M Bueno; Claudia A Riedel; Alexis M Kalergis
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-25       Impact factor: 11.205

Review 7.  Helicobacter and salmonella persistent infection strategies.

Authors:  Denise M Monack
Journal:  Cold Spring Harb Perspect Med       Date:  2013-12-01       Impact factor: 6.915

8.  Selectively reduced intracellular proliferation of Salmonella enterica serovar typhimurium within APCs limits antigen presentation and development of a rapid CD8 T cell response.

Authors:  Homam Albaghdadi; Nirmal Robinson; Brett Finlay; Lakshmi Krishnan; Subash Sad
Journal:  J Immunol       Date:  2009-08-19       Impact factor: 5.422

9.  Functional analysis of the Salmonella pathogenicity island 2-mediated inhibition of antigen presentation in dendritic cells.

Authors:  Serkan Halici; Sebastian F Zenk; Jonathan Jantsch; Michael Hensel
Journal:  Infect Immun       Date:  2008-09-02       Impact factor: 3.441

10.  The Salmonella SPI2 effector SseI mediates long-term systemic infection by modulating host cell migration.

Authors:  Laura M McLaughlin; Gregory R Govoni; Christiane Gerke; Smita Gopinath; Kaitian Peng; Grace Laidlaw; Yueh-Hsiu Chien; Ha-Won Jeong; Zhigang Li; Matthew D Brown; David B Sacks; Denise Monack
Journal:  PLoS Pathog       Date:  2009-11-26       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.